Found "Public health policy": 1,126 results
Sort by
Sort by
Last updated
Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
Cetuximab is provided for mCRC patients with positive KRAS wild type, and also head and neck cancer patients as indicated in the Indonesian National Drug Formulary. However, currently, it is also used for indications not specified in the National Drug Formulary.
Adding cetuximab to chemothera
Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
In many countries, rotavirus vaccination is the most cost-effective way to prevent rotavirus diarrhea. With this in mind, the Essential Medicines and Technology Division (EMTD) in collaboration with Health Intervention Technology Assessment Program (HITAP), Mahidol Oxford Research Unit (MORU), and P
Building Global Health Capacity for Countries in WHO South-East Asia Region
Global health is defined as health issues that transcend national boundaries. This notion implies a shared global responsibility for health and is associated with actors beyond country government. In WHO South-East Asia Region (SEAR), the Regional Committee adopted a resolution in 2010 to enco
Budgeting and paying for services under Thailand’s Universal Coverage Scheme
Health financing is a component of the health system, crucial in achieving universal health coverage (UHC). Careful design of its three main functions, resource mobilisation, pooling and allocation, ensures improved access to essential health services and financial risk protection for
Evaluating the Value of a Real-World HTA Agency
As countries develop their health systems on the path to Universal Health Coverage (UHC) (#LeaveNoOneBehind), many countries are experimenting with the development of a health technology assessment (HTA) agency in order to set priorities for health benefit packages, make go/no go decisions about
Addressing Antimicrobial Resistance in Thailand: A Policy Overview
Antimicrobial Resistance (AMR) occurs when pathogens (bacteria, viruses, fungi, and parasites) develop a resistance or tolerance to the medicines that are used to combat these microorganisms, such that these treatments are no longer effective. AMR has been increasing in low-, middle- and high-income
Which investment on interventions against COVID-19 pandemic is worth its cost?
Various public health measures have been taken by governments and health authorities to prevent and control pandemics across time. The benefit of investing in any health condition should outweigh the costs of not investing in it. The objective of this evidence brief to review studies conducted
10 / Page